Login / Signup

A Comparative Analysis of Weizmannia coagulans Genomes Unravels the Genetic Potential for Biotechnological Applications.

Martina AulittoMartínez-Alvarez LauraGabriella FiorentinoDanila LimauroPeng XuPatrizia Contursi
Published in: International journal of molecular sciences (2022)
The production of biochemicals requires the use of microbial strains with efficient substrate conversion and excellent environmental robustness, such as Weizmannia coagulans species. So far, the genomes of 47 strains have been sequenced. Herein, we report a comparative genomic analysis of nine strains on the full repertoire of Carbohydrate-Active enZymes (CAZymes), secretion systems, and resistance mechanisms to environmental challenges. Moreover, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) immune system along with CRISPR-associated (Cas) genes, was also analyzed. Overall, this study expands our understanding of the strain's genomic diversity of W. coagulans to fully exploit its potential in biotechnological applications.
Keyphrases
  • genome wide
  • genome editing
  • crispr cas
  • escherichia coli
  • copy number
  • human health
  • dna methylation
  • life cycle
  • genetic diversity
  • structural basis